Inhibition of IAP (inhibitor of apoptosis) proteins represses inflammatory status via nuclear factor‐kappa B pathway in murine endometriosis lesions
article
OA: closed
CC0
⤵ 6 in-corpus citations
AI-generated summary
The IAP antagonist BV6 reduced endometriotic lesion size and inflammatory gene expression in mice by inhibiting the NF-κB pathway.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Problem How is the role of inhibitor of apoptosis proteins ( IAP s) in the development of murine endometriosis lesions? Method of study BALB /c female mice (n = 36) were used for the murine endometriosis model. Endometriotic lesions were surgically induced in mice by transplanting mouse uterine tissue. After 4 weeks of IAP antagonist ( BV 6) treatment, the expression of inflammatory factors in the implants was evaluated using real‐time RT ‐ PCR . Inflammatory state, angiogenic activity, and nuclear factor‐kappa B ( NF ‐κB) activation were assessed by immunohistochemical staining. Results The number, size, and level of inflammatory cytokines (Vegf , Il‐6 , Ccl‐2, Lif ) gene expression in the murine endometriosis‐like lesions were reduced by BV 6 treatment. BV 6 repressed the intensity and rate of positive cells of CD 3, F4/80, and PECAM immunostaining; in addition, the expression of NF ‐κB p65 and phospho‐ NF ‐κB p65 was also attenuated. Conclusion Inhibitor of apoptosis proteins antagonist represses the inflammation status of murine endometriosis‐like lesions via NF ‐κB pathway. IAP s may be a novel therapeutic target for endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (33)
- Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues via openalex
- Evaluation and management of women with endometriosis via openalex
- Evaluation and Management of Women With Endometriosis via openalex
- Immunobiology of endometriosis via openalex
- Lipopolysaccharide promotes the development of murine endometriosis‐like lesions via the nuclear factor‐kappa B pathway via openalex
- Parthenolide reduces cell proliferation and prostaglandin estradiol synthesis in human endometriotic stromal cells and inhibits development of endometriosis in the murine model via openalex
- Pathogenetic Significance of Increased Levels of Interleukin-8 in the Peritoneal Fluid of Patients with Endometriosis via openalex
- Peritoneal fluid cytokines related to endometriosis in patients evaluated for infertility via openalex
- Role of cytokines in endometriosis via openalex
- Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer via openalex
- TAK1 activation for cytokine synthesis and proliferation of endometriotic cells via openalex
- The Cellular Inhibitor of Apoptosis Protein‐2 is a Possible Target of Novel Treatment for Endometriosis via openalex
- The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis via openalex
- Tumor Necrosis Factor-α-Induced Interleukin-8 (IL-8) Expression in Endometriotic Stromal Cells, Probably through Nuclear Factor-κB Activation: Gonadotropin-Releasing Hormone Agonist Treatment Reduced IL-8 Expression via openalex
- W1492587973 via openalex
- W2064299413 via openalex
- W2069800916 via openalex
- W2069990321 via openalex
- W2085018432 via openalex
- W2091269867 via openalex
- W2095280500 via openalex
- W2102675401 via openalex
- W2107890932 via openalex
- W2167318005 via openalex
- W2277353857 via openalex
- W1976457595 via openalex
- W1996123579 via openalex
- W1998918148 via openalex
- W2002154440 via openalex
- W1989277510 via openalex
- W1984909958 via openalex
- W2029595161 via openalex
- W1983814994 via openalex
Cited by (6)
- An Update on the Multifaceted Role of NF-kappaB in Endometriosis 2022
- Animal models for research on endometriosis 2020
- Involvement of angiotensin II receptor type 1/NF‑κB signaling in the development of endometriosis 2020
- Tokishakuyakusan, a Kampo medicine, attenuates endometriosis‐like lesions and hyperalgesia in murine with endometriosis‐like symptoms 2019
- Analysis of key candidate genes and pathways of endometriosis pathophysiology by a genomics-bioinformatics approach 2019
- [Research progress on roles of vitamin D in endometriosis]. 2018
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:07.505861+00:00
License: CC0
· commercial use OK